Abstract:(1) C10 and C8 accumulate in the brain and enter neuronal cells. (2) C8 is preferentially oxidised by mitochondria over C10, allowing for the intracellular accumulation of C10. (3) C10 interacts with the nuclear receptor PPARγ, leading to the upregulation of target genes and subsequently, (4), increased mitochondrial and peroxisomal biogenesis. (5) this increase in cellular mitochondrial and peroxisomal content is thought to have several beneficial effects on neuronal function, including improved energy metabolism, antioxidant status and lipid homeostasis. Medium‐chain fatty acids (MCFAs), particularly decanoic acid (C10) and octanoic acid (C8), have garnered attention in recent years for their potential antiepileptic properties. A previous study from our laboratory demonstrated that C10 targets the PPARγ nuclear receptor, increasing the activity of the antioxidant enzyme catalase and thereby possibly modulating peroxisomal content. Here, we examined markers of peroxisomal content and activity in response to C10 and C8 exposure in neuronal‐like SH‐SY5Y cells. SH‐SY5Y were treated with 250 mM C10 or C8 for a period of 6 days. Following this, biochemical markers of peroxisomal content and function were assessed, including acyl‐coA oxidase activity, peroxisomal gene expression and peroxisomal VLCFA β‐oxidation. Our findings revealed that C10 treatment augments acyl‐CoA oxidase 1 (ACOx1) activity by 129% in comparison to control cells. An exploration into genes related to peroxisomal biosynthesis showed 23% increased expression of PEX11α upon C10 exposure, implying peroxisomal proliferation. Furthermore, it was observed that C10 exposure not only elevated ACOx1 activity but also enhanced peroxisomal β‐oxidation of docosanoic acid (C22). Our findings bolster the premise that C10 functions as a peroxisome proliferator, influencing peroxisomal content and function. Further investigations are required to fully understand the mechanistic details as to how this may be beneficial in epilepsy and the potential implications with regards to peroxisomal disease.

Histiocytic lymphoma presenting with extrahepatic biliary obstruction: a report of three cases.

Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor α agonists

PPARα Induces the Expression of CAR That Works as a Negative Regulator of PPARα Functions in Mouse Livers

Infectivity of Cryptosporidium parvum oocysts stored in water at environmental temperatures.

Bubbles in an infant oxygenator at very low flow rates.

Pgc-1 Alpha Inhibits Oleic Acid Induced Proliferation And Migration Of Rat Vascular Smooth Muscle Cells

TE01 mode converter for highly overmoded circular waveguide at 188 GHz

Critical role of peroxisome proliferator-activated receptor a in promoting platelet hyperreactivity and thrombosis under hyperlipidemia

Study of actin filament ends in the human red cell membrane.

Coadministration Of A Liver X Receptor Agonist And A Peroxisome Proliferator Activator Receptor-Alpha Agonist In Mice: Effects Of Nuclear Receptor Interplay On High-Density Lipoprotein And Triglyceride Metabolism In Vivo

Constitutive androstane receptor weakens the induction of panaxytriol on CYP3A4 by repressing the activation of pregnane X receptor

Hepatic expression of thyroid hormone-responsive spot 14 protein is regulated by constitutive androstane receptor (NR1I3)

CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice

SH‐SY5Y cells undergo changes in peroxisomal metabolism when exposed to decanoic acid

Monocarboxylate transporter 1 and CD147 are up-regulated by natural and synthetic peroxisome proliferator-activated receptor alpha agonists in livers of rodents and pigs

Ca(2+)-dependent mitogen-activated protein kinase activation in spontaneously hypertensive rat vascular smooth muscle defines a hypertensive signal transduction phenotype.

PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.

Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPARα activation

Phylogenetic evidence of a role for 5-hydroxymethyluracil-DNA glycosylase in the maintenance of 5-methylcytosine in DNA.

Farnesoid X Receptor Activation Increases Cholesteryl Ester Transfer Protein Expression in Humans and Transgenic Mice

The ryanodine receptor: a pivotal Ca2+ regulatory protein and potential therapeutic drug target.